Mike Polark
Stock Analyst at Baird
(3.28)
# 1,076
Out of 4,415 analysts
63
Total ratings
46.15%
Success rate
3.28%
Average return
Main Sectors:
23 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIVN LivaNova | Maintains: Neutral | $58 → $66 | $62.92 | +4.90% | 6 | May 2, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $440 → $436 | $381.36 | +14.33% | 5 | Apr 19, 2024 | |
| SWAV ShockWave Medical | Downgrades: Peer Perform | n/a | $330.38 | - | 2 | Apr 5, 2024 | |
| NVRO Nevro | Maintains: Neutral | $23 → $19 | $11.15 | +70.40% | 7 | Feb 22, 2024 | |
| AXNX Axonics | Downgrades: Peer Perform | n/a | $67.11 | - | 3 | Jan 9, 2024 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $57 | $85.25 | -33.14% | 2 | Nov 28, 2023 | |
| SILK Silk Road Medical | Upgrades: Peer Perform | n/a | $18.90 | - | 4 | Oct 24, 2023 | |
| RMD ResMed | Downgrades: Peer Perform | n/a | $216.98 | - | 4 | Sep 29, 2023 | |
| ABT Abbott Laboratories | Upgrades: Peer Perform | n/a | $105.90 | - | 3 | Jul 21, 2023 | |
| IRTC iRhythm Technologies | Initiates: Outperform | $130 | $102.68 | +26.61% | 4 | Jul 19, 2023 | |
| INSP Inspire Medical Systems | Initiates: Outperform | $371 | $249.72 | +48.57% | 3 | Jul 19, 2023 | |
| TFX Teleflex | Downgrades: Peer Perform | n/a | $198.73 | - | 3 | Apr 26, 2023 | |
| DXCM DexCom | Initiates: Outperform | $121 | $128.37 | -5.74% | 1 | Jan 26, 2023 | |
| PODD Insulet | Initiates: Peer Perform | n/a | $174.43 | - | 1 | Jan 26, 2023 | |
| TNDM Tandem Diabetes Care | Initiates: Peer Perform | n/a | $44.72 | - | 1 | Jan 26, 2023 | |
| SHC Sotera Health Company | Upgrades: Outperform | $25 | $10.91 | +129.15% | 4 | Jan 11, 2023 | |
| MASI Masimo | Upgrades: Outperform | $165 | $137.00 | +20.44% | 3 | Sep 15, 2022 | |
| BSX Boston Scientific | Initiates: Outperform | n/a | $72.85 | - | 1 | Jul 6, 2022 | |
| MDT Medtronic | Initiates: Underperform | n/a | $81.69 | - | 1 | Jul 6, 2022 | |
| NPCE NeuroPace | Initiates: Outperform | $13 | $13.64 | -4.69% | 2 | Apr 6, 2022 | |
| NYXH Nyxoah | Initiates: Peer Perform | $21 | $9.82 | +113.85% | 1 | Apr 6, 2022 | |
| STE STERIS | Maintains: Outperform | n/a | $207.82 | - | 1 | Aug 11, 2021 | |
| BEAT HeartBeam | Initiates: Neutral | n/a | $2.21 | - | 1 | Sep 2, 2020 |
LivaNova
May 2, 2024
Maintains: Neutral
Price Target: $58 → $66
Current: $62.92
Upside: +4.90%
Intuitive Surgical
Apr 19, 2024
Maintains: Outperform
Price Target: $440 → $436
Current: $381.36
Upside: +14.33%
ShockWave Medical
Apr 5, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $330.38
Upside: -
Nevro
Feb 22, 2024
Maintains: Neutral
Price Target: $23 → $19
Current: $11.15
Upside: +70.40%
Axonics
Jan 9, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $67.11
Upside: -
Edwards Lifesciences
Nov 28, 2023
Downgrades: Underperform
Price Target: $57
Current: $85.25
Upside: -33.14%
Silk Road Medical
Oct 24, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $18.90
Upside: -
ResMed
Sep 29, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $216.98
Upside: -
Abbott Laboratories
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $105.90
Upside: -
iRhythm Technologies
Jul 19, 2023
Initiates: Outperform
Price Target: $130
Current: $102.68
Upside: +26.61%
Inspire Medical Systems
Jul 19, 2023
Initiates: Outperform
Price Target: $371
Current: $249.72
Upside: +48.57%
Teleflex
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $198.73
Upside: -
DexCom
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $128.37
Upside: -5.74%
Insulet
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $174.43
Upside: -
Tandem Diabetes Care
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $44.72
Upside: -
Sotera Health Company
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $10.91
Upside: +129.15%
Masimo
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $137.00
Upside: +20.44%
Boston Scientific
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $72.85
Upside: -
Medtronic
Jul 6, 2022
Initiates: Underperform
Price Target: n/a
Current: $81.69
Upside: -
NeuroPace
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $13.64
Upside: -4.69%
Nyxoah
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $9.82
Upside: +113.85%
STERIS
Aug 11, 2021
Maintains: Outperform
Price Target: n/a
Current: $207.82
Upside: -
HeartBeam
Sep 2, 2020
Initiates: Neutral
Price Target: n/a
Current: $2.21
Upside: -